image description

Krishna Veeraraghavan


Krishna Veeraraghavan

New York +1-212-558-4000+1-212-558-4000 +1-212-558-3588+1-212-558-3588
veera[email protected]

Recognized twice as “Dealmaker of the Week” by The American Lawyer, for his work on M&A mega-deals by The Legal 500 and as a “Highly Regarded Lawyer” by IFLR1000, Krishna Veeraraghavan is a partner and member of S&C’s Mergers and Acquisitions Group. Mr. Veeraraghavan has a broad multidisciplinary practice that includes extensive experience in mergers and acquisitions and corporate governance. He has been engaged in many high profile matters that include activism, cross-border transactions, leveraged buyouts, proxy contests and unsolicited bids as an adviser to global leaders such as, AB InBev, AT&T, BHP Billiton, CA Technologies, Praxair and Teva Pharmaceuticals. Mr. Veeraraghavan also regularly counsels boards of directors and board committees on corporate governance, crisis management and matters affecting corporate policy and strategy. He is an adjunct professor at Columbia Law School.  Over the past three years he has advised on a variety of matters including:

Consumer & Retail and Industrials

  • General Cable in its $3 billion pending acquisition by Prysmian Group
  • in its $13.7 billion acquisition of Whole Foods
  • Praxair in its $73 billion pending merger with Linde
  • Lion Capital in its $1.5 billion sale of Bumble Bee Foods to Thai Union Frozen Products, later withdrawn
  • Standard Industries in its $2.1 billion acquisition of Braas Monier; $1.1 billion acquisition of Icopal; and acquisition of Quest Construction Products
  • AB InBev in its $123 billion merger with SABMiller and $20.1 billion acquisition of the remaining stake in Grupo Modelo

Healthcare & Life Sciences

  • Seattle Genetics in its $614 million pending acquisition of Cascadian Therapeutics
  • Syneos Health (formerly INC Research) in its $7.4 billion merger of equals with inVentiv Health
  • Stemcentrx in its $9.8 billion acquisition by AbbVie
  • Teva in its $40.5 billion acquisition of Allergan and $50.5 billion unsolicited proposal for Mylan, later withdrawn
  • Dyax in its $5.9 billion acquisition by Shire
  • Synageva in its $8.4 billion acquisition by Alexion
  • Cyberonics in its $1.5 billion merger with Sorin to create LivaNova
  • LabCorp in its $6.1 billion acquisition of Covance
  • Idenix in its $3.85 billion acquisition by Merck

Real Estate

  • American Casino & Entertainment Properties in its $850 million acquisition by Golden Entertainment
  • Special Committee of Forest City Realty Trust in connection with the company's agreement to declassify its common stock and its settlement with Scopia Capital Management


  • in its pending agreement with Plug Power to utilize Plug Power fuel cells and hydrogen technology in its fulfillment network
  • Special Committee of Solera Holdings in connection with its $6.5 billion acquisition by Vista Equity Partners


  • Andeavor in the merger of Andeavor Logistics and Western Refining Logistics for $1.8 billion and the repositioning of Andeavor Logistics through an IDR buy-in valued at $4 billion
  • Cheniere Energy in its proposal to the board of directors of Cheniere Energy Partners to acquire Cheniere Energy Partners
  • BHP Billiton in its $15.1 billion acquisition of Petrohawk Energy
Mr. Veeraraghavan is consistently recognized as a leading M&A advisor for his corporate, M&A and governance representations by Chambers USA, Law360 and New York Super Lawyers. He has also been named a Law360 “Retail & E-Commerce MVP” and “Life Sciences MVP,” a “Transatlantic Rising Star” by The American Lawyer, a “Rising Star” by both Law360 and New York Law Journal and named among the “Best Lawyers Under 40” by the National Asian Pacific American Bar Association and The M&A Advisor. Additional accolades include being named a Finalist for “Legal Advisor of the Year” by The M&A Advisor, an Empire State Counsel Honoree for Pro bono Service by the New York State Bar Association and one of four “Rising Stars” by the Minority Corporate Counsel Association.

In addition to being an adjunct professor, Mr. Veeraraghavan is a member of the Steering Committee of the Board of Visitors at Columbia Law School and is on the advisory board for the school’s Blue Sky Blog. Mr. Veeraraghavan is a member of the American Bar Association’s Committee on Mergers and Acquisitions and holds several board memberships, including the American India Foundation and South Asian Youth Action. In 2013, he was named a Fellow by the Leadership Council on Legal Diversity.

  • “2016 Mergers and Acquisitions Report: United States” International Finance Law Review (co-author)
  • “Merger Market Perspective: Opportunities and Legal Issues in FinTech M&A,” FinTech Law Report (co-author)
  • “The Continuing Importance of Process in Entire Fairness Review: In re Nine Systems,” Deal Lawyers (co-author)
  • “Model Provision for Merger Agreement (Tender Offer),” Practical Law: The Journal (co-author)
  • “2015 Mergers and Acquisitions Report: United States” International Finance Law Review (co-author)
  • “The Proxy Put and Fiduciary Duties: A Closer Look at Kallick v. SandRidge,” The M&A Lawyer (co-author)
  • “The Uncertain Relationship Between Fiduciary Waivers & the Implied Covenant of Good Faith in Delaware Alternative Entity Law,” The M&A Lawyer (co-author)
  • “Using Option Structures to Reduce Buyer Risk in Pharmaceutical M&A Deals,” Practical Law Company practice note (co-author)
  • “Qualitative Disclosure & Financial Projects: Overshadowed Lessons from In re,” Columbia Law School’s Blue Sky Blog (co-author)
  • “Confidentiality Agreements: Lessons from Delaware,” Bloomberg Law – Practitioner Contributions (co-author)
  • “Recent Delaware Developments: Three Cases with Surprising Outcomes that Reinforce Traditional Fiduciary Principles,” Columbia Law School’s Blue Sky Blog (co-author)
  • “What You Need to Know Before You Receive an Unsolicited Bid,” The M&A Lawyer (co-author)
  • “Memo to the Board of Directors: Preparing for 2013,” Bloomberg/BNA’s Corporate Accountability Report (co-author)
  • “Preparing and Disclosing Financial Projections in Public M&A,” Practical Law: The Journal (co-author)
  • “FCPA for Dealmakers: A Tutorial,” The Deal Pipeline (co-author)
  • “What You Need to Know About the FCPA Before You Do Your Next Deal,” The M&A Lawyer (co-author)